HIGHLIGHTS
- who: Xue Liu from the Institut Gustave Roussy, France University of Rome Tor Vergata, Italy have published the paper: Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis, in the Journal: (JOURNAL) of 30/09/2021
- what: The aim of this meta-analysis and systematic review was to evaluate the application value of 18F-PSMA1007 PET/CT in patients with different serum PSA levels in the setting of primary staging of PCa . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.